Home | Advanced Search | Downloads | Login | Contact Us
Company   Technology Platforms   Investor Relations   News & Information   Contact Us
Stock Quote
QMDT
Current:  
Date:
Time:
Change:


Quick-Med Technologies, Inc. is a publicly traded Company listed under the symbol “QMDT” on the OTC Bulletin Board.

Shareholders Services
For assistance with most services related to stock ownership, contact our transfer agent, Continental Stock Transfer & Trust Company at 212.509.4000, or by e-mail at cstmail@continentalstock.com

Investor Relations
Shareholders, securities, analysts, and investors seeking additional information about the company, please contact at 561-771-1307, or by email at info@quickmedtech.com

 
11/18/2008 - New Study Reaffirms Quick-Med’s NIMBUS® Technology Poses No Threat of Bacterial Resistance

Gainesville, Florida – November 18, 2008 – Quick-Med Technologies, Inc. announced today that Dr. Albina Mikhaylova, Senior Scientist at Quick-Med, presented conclusive evidence at the Symposium on Skin and Wound Care that the Company’s patented NIMBUS® antimicrobial technology poses no threat of bacterial resistance. The findings, presented in a podium session at this leading meeting of wound care practitioners, are in sharp contrast to known resistance issues with leading antibiotics that have allowed soaring hospital acquired infection rates seen worldwide.
Read More...
06/11/2008 - Quick-Med Technologies, Inc. Signs Manufacturing and Distribution Agreement with BASF Beauty Care Solutions

Gainesville, Florida – June 11, 2008 - Quick-Med Technologies, Inc. announced today that it has entered into a new multi-year exclusive worldwide Manufacturing and Distribution Agreement with BASF Beauty Care Solutions, L.L.C., to manufacture and distribute Quick-Med’s proprietary anti-aging technology MultiStat for use in cosmetics.
Read More...
05/21/2008 - NIMBUS®, NimbuDerm™ and MultiStat™ Technologies Selected for Presentation at Prestigious 3rd Congress of the World Union of Wound Healing Societies in Toronto
05/15/2008 - Quick-Med’s Novel Wound Dressing Receives Recognition from the Wound Healing Society
05/14/2008 - NimbuDerm™ Receives Wound Healing Society’s Blue Ribbon Award
04/10/2008 - Quick-Med Technologies, Inc. Signs Joint Development Agrement with a Leading Provider of Health Care Products
04/08/2008 - Quick-Med Technologies Presenting at Prestigious SAWC/WHS Conference
03/11/2008 - Quick-Med Technologies is Developing a Next Generation Skin Sanitizer Technology to Provide Long-Lasting Protection from MRSA
02/12/2008 - Quick-Med Technologies’ Research & Development Center Moves to New Location
02/01/2008 - Dr. Olderman Highlights the Value of a Bonded Antimicrobial at Textiles Conference
08/09/2007 - Quick-Med Technologies Announces CEO Appointment
08/02/2007 - Mexico grants Quick-Med Technologies, Inc. Notice of Allowance for its NIMBUS® Technology
06/19/2007 - Quick-Med Technologies, Inc. and the University of Michigan Sign Patent Licensing Agreement
04/24/2007 - Quick-Med Technologies, Inc. Awarded $1 Million Congressional Appropriation
04/02/2007 - Quick-Med Technologies, Inc. Licenses NIMBUS Anti microbial Technology To Derma Sciences, Inc. For Use In Wound Care Products
03/26/2007 - Quick-Med Technologies' Lead Molecule Ilomastat Selected for Evaluation in Sulfur Mustard Gas Grant from NIH
07/10/2006 - Quick-Med Technologies, Inc. Resolves Dispute With Cosmetics Distribution Partner
07/26/2006 - Quick-Med Technologies, Inc. Competitively Selected By U.S. Army For a $770,000 Phase II SBIR Grant
06/01/2006 - Quick-Med Technologies, Inc. to Address Congressional 21st Century Health Care Caucus on Hospital Infection Prevention
05/31/2006 - Quick-Med Technologies, Inc. Receives Wound Healing Society's Prestigious Blue Ribbon Award
03/16/2006 - Quick-Med Technologies, Inc. Senior Scientist Gregory S. Schultz Profiled in TIME Magazine
01/09/2006 - Cheryl L. Turnbull Elected to Board of Directors of Quick-Med Technologies, Inc.
12/08/2005 - Quick-Med Technologies, Inc. Receives Key Patent On Its NIMBUS™ Technology U.S. Patent Allowance Significantly Strengthens Overall Patent Portfolio
11/15/2005 - Quick-Med Technologies, Inc. Awarded U.S. Army SBIR Phase I Contract
09/13/2005
- Quick-Med Technologies, Inc. and The University of Florida Collaborate to Develop The Next Generation of NIMBUS™ Anti microbial Technology

01/13/2005 - Quick-Med Technologies, Inc. Retains Elman Technology Law, P.C.
News Archive...
 

Time MagazineTime Magazine - Index: March 20, 2006 Vol. 167 No. 12
Sunday, Mar. 12, 2006
What's Next? The Next Big Thing Is Us....
Innovators / Epidemiology: Forging the Future
Microbe-Busting Bandages
By SIOBHAN MORRISSEY/MIAMI

What do jock itch, poison gas and flesh-eating bacteria have in common? Gregory Schultz, 56, thinks he has the answer. The cancer researcher turned inventor has patented a technique for chemically bonding bacteria-fighting polymers to such fabrics as gauze bandages, cotton T shirts and men's underpants. It's a technology with an unusually wide variety of uses, from underwear that doesn't stink to hospital dressings that thwart infections.

To read full article click here...

 
SEC Filings
What's New?
Company Information
Board of Directors
Corporate Governance

Investor Relations
Company Information
Board of Directors
Corporate Governance
SEC Filing
News Releases


Enlarge Text Tool
Increase Text Size Decrease Text Size



I am particularly impressed by the magnitude of the advantages offered by Quick-Med Technologies, the breadth and size of their potential markets, and the energy and persistence of the company’s management.”


James E. Wiggins, General Partner of Phronesis Partners, L.P.

Company | Technology Platforms | Investor Relations | News & Information | Contact Us | Search | Terms of Use
Copyright ©2002-2008 Quick-Med Technologies Inc. All Rights Reserved.